genia tagger: 187('all', 159)
('influenza', 4)
('alleles', 2)
('in-house', 6)
('hla-drb1', 2)
('il\\-15\\.', 6)
('percp', 2)
('mnc', 12)
('cytokines', 8)
('blocked', 4)
('kir-ligands', 1)
('cd34\\+', 8)
('group', 32)
('persistent', 2)
('\\?', 42)
('mm\\/nk', 4)
('receptors', 10)
('interleukin-2', 2)
('cd158b', 4)
('enriched', 8)
('fig', 48)
('nkb1', 4)
('factor', 4)
('lymphocytes', 2)
('allele', 18)
('\\,', 532)
('donor-derived', 2)
('\\(', 334)
('\\)', 334)
('hla-c', 36)
('hla-abc', 2)
('chlorophyll-alpha', 2)
('killer', 3)
('dc', 2)
('mismatched', 16)
('cd3', 40)
('cd3-depleted', 2)
('2', 452)
('recipient', 87)
('kir-receptor', 4)
('beads', 2)
('anti-kir', 2)
('summary', 1)
('anti-cd3', 2)
('t', 4763)
('release', 10)
('tnf-', 8)
('ifn', 10)
('pro-inflammatory', 8)
('investigators', 6)
('hla\\-c\\*0304', 2)
('post-infusion', 4)
('triplicate', 2)
('antigen', 5)
('\\/kir', 4)
('supplementary', 2)
('growth', 2)
('mlrs', 4)
('apc', 4)
('targets', 4)
('hla', 82)
('inhibitory', 5)
('endotoxin', 10)
('cell', 488)
('il-4', 6)
('cd14', 2)
('cd15', 10)
('principal', 4)
('il-6', 6)
('cd19', 2)
('cd4\\+', 16)
('kir-ligand', 15)
('patient', 203)
('k562', 27)
('lymphocyte', 10)
('cd3\\+', 16)
('stem', 9)
('109', 30)
('wells', 2)
('cd3\\+\\/4\\+', 4)
('mononuclear', 2)
('standard', 16)
('neutrophil', 4)
('anti-human', 3)
('w6\\/32', 6)
('sensitive', 4)
('transplantation', 2)
('products', 51)
('mixed', 2)
('toxicity', 16)
('antibody', 5)
('ex-vivo', 2)
('interferon', 2)
('assays\\.', 2)
('hla\\-bw4\\.', 4)
('primary', 24)
('peridinin', 2)
('receptor', 18)
('0\\.038', 8)
('infiltrating', 2)
('table', 20)
('cells\\.', 41)
('\xc3\x97', 58)
('\\/l', 34)
('pr', 377)
('u266', 25)
('tumour', 10)
('hlac\\*', 2)
('t-cell', 9)
('therefore', 14)
('4-h', 2)
('cultures', 2)
('expanded', 2)
('monoclonal', 2)
('4', 148)
('resting', 12)
('cd56', 10)
('aphaeresis', 12)
('populations', 10)
('8', 84)
('line', 23)
('population', 22)
('count', 30)
('immunoglobulin-like', 2)
('mm', 147)
('cells', 279)
('cd158a', 4)
('flu', 33)
('malignancies\\.', 2)
('cytokines\\.', 4)
('tnf', 10)
('mr', 4)
('allo-reactive', 26)
('leucocyte', 1)
('autologous', 18)
('ifn-', 8)
('cba', 2)
('figure', 6)
('nkg2a\\+\\/kir', 2)
('alloreactive', 4)
('hlabw4', 4)
('interleukin-15', 1)
('ii', 6)
('transfused', 27)
('interactions\\.', 4)
('pha-blasts', 10)
('protein', 2)
('pneumonia\\.', 4)
('nk', 320)
('s3', 6)
('s2', 6)
('s1', 8)
('il-15', 48)
('-ligand', 18)
('il-10', 6)
('1', 365)
('haplo-identical', 17)
('donor', 151)
('several', 4)
('hla-a', 4)
('european', 4)
('product', 89)
('material', 2)
('cytokine', 16)
('normal', 14)
('fitc', 4)
('kir', 88)
('pha', 33)
('cd33', 2)
('il-2', 56)
('51cr', 2)
('virus', 8)
('mab', 2)
('0702', 2)
('ab', 129)
('class', 18)
('a', 4120)
('natural', 1)
('i', 4346)
('necrosis', 2)
('responder', 6)
('lines', 8)
('myeloma', 6)
('hla-ligand', 2)
('cd56\\+', 4)
('cs1', 2)
('discussion', 2)


spacy + metamap: 534('positive control', 4)
('delivery', 2)
('alleles', 2)
('epigenetic silencing', 2)
('four', 14)
('acute myeloid leukaemia', 1)
('primer', 2)
('cytokines', 8)
('content', 2)
('amplification', 2)
('mediated', 12)
('protocols', 2)
('immature', 2)
('heterogeneity', 2)
('endogenous', 5)
('brown', 2)
('assay', 18)
('chiron', 2)
('\\+2', 2)
('phycoerythrin', 2)
('steady state', 2)
('condition', 18)
('timely', 4)
('engraftment', 4)
('level', 40)
('large', 10)
('nk cell function', 2)
('allophycocyanin', 2)
('cell lines', 8)
('blade', 2)
('hypotensive episode', 8)
('occurrence', 2)
('ten', 72)
('triplicate', 2)
('miller', 10)
('rate', 34)
('salvage therapy', 2)
('further', 20)
('elisa', 2)
('aim', 2)
('abc', 2)
('cd158a', 4)
('clinical response', 2)
('new', 4)
('increasing', 21)
('method', 5)
('transplant procedure', 2)
('fungal pneumonia', 4)
('\\>5', 4)
('genotyping', 10)
('residual', 4)
('normal tissue', 4)
('others', 2)
('active', 36)
('donor selection', 4)
('kir receptor', 8)
('institutional review board', 2)
('healthy', 4)
('study', 18)
('larger', 2)
('step', 4)
('killer immunoglobulin-like receptor', 2)
('products', 51)
('flu', 33)
('toxicity', 16)
('studies', 7)
('high resolution', 2)
('interferon', 2)
('family', 2)
('marked', 4)
('peridinin', 2)
('apc', 4)
('total', 4)
('transplant', 22)
('allogeneic', 2)
('usa', 18)
('complete remission', 1)
('positive', 12)
('two', 30)
('next', 8)
('criteria', 10)
('manufacturer', 2)
('more', 20)
('0\\%', 33)
('populations', 10)
('immunoglobulins', 2)
('mismatch', 18)
('infusion', 106)
('infection', 10)
('tandem', 6)
('cases', 4)
('blocking', 11)
('97', 4)
('insights', 2)
('account', 2)
('ml', 28)
('mn', 14)
('million units', 2)
('fludarabine', 5)
('tnf', 10)
('era', 81)
('mr', 4)
('early relapse', 4)
('salvage', 16)
('liposomal', 4)
('control', 20)
('peak level', 4)
('process', 16)
('high', 17)
('kir2dl2', 12)
('kir2dl1', 4)
('numbers', 6)
('serial', 4)
('serum', 16)
('absolute', 16)
('recovery', 4)
('s3', 6)
('s2', 6)
('s1', 8)
('six', 4)
('cell-mediated cytotoxicity', 4)
('product', 89)
('cytokine', 16)
('rigors', 4)
('fitc', 4)
('clone', 2)
('cd33', 2)
('cd34', 8)
('american red cross', 2)
('modest', 4)
('mab', 2)
('multiple myeloma', 1)
('data', 23)
('response', 27)
('effective', 8)
('t cells', 20)
('stable disease', 6)
('first', 20)
('cs1', 2)
('discussion', 2)
('sd', 8)
('transplants', 2)
('k562 cells', 8)
('years', 4)
('experiments', 2)
('same', 4)
('infusion reaction', 2)
('kbq', 2)
('nkg2a', 4)
('superior', 4)
('group', 32)
('ligand', 35)
('\\>97', 2)
('allo', 60)
('late', 35)
('window', 2)
('production', 2)
('fig', 48)
('donors', 22)
('non', 8)
('good', 4)
('remission', 6)
('auto', 54)
('practice', 4)
('primary', 24)
('therapy', 34)
('effects', 10)
('day', 40)
('instructions', 2)
('very large tumour', 2)
('university', 2)
('drop', 2)
('conditioning regimen', 5)
('normal cell', 2)
('mean', 2)
('week', 6)
('molecular typing', 2)
('house', 6)
('related', 9)
('autologous stem cell transplantation', 1)
('doses', 10)
('lysis', 24)
('event', 11)
('hla', 82)
('herpes simplex virus', 4)
('malignancies', 2)
('increase', 12)
('mate', 14)
('arkansas', 2)
('derived', 2)
('standard', 16)
('conditioning', 16)
('dexamethasone', 2)
('peripheral blood', 4)
('interaction', 9)
('kir ligand', 8)
('days', 8)
('times', 4)
('r-', 35)
('chills', 4)
('hla class i', 18)
('degree', 2)
('steroids', 4)
('number', 31)
('one', 44)
('body weight', 8)
('array', 4)
('size', 2)
('carson', 2)
('genotype', 2)
('mixed lymphocyte culture', 2)
('nk cells', 118)
('system', 4)
('approximately', 6)
('stimulation', 2)
('typing', 34)
('chemotherapy', 2)
('percentage', 20)
('cell interaction', 5)
('final', 2)
('schema', 2)
('testing', 10)
('hla-bw4', 8)
('stem cell', 5)
('population', 22)
('wide', 4)
('viable cells', 2)
('target', 9)
('double', 4)
('transferred', 2)
('preparation', 4)
('pneumonia', 8)
('patients', 161)
('future', 3)
('outcome', 16)
('treated', 22)
('pre', 137)
('chlorophyll', 2)
('san', 6)
('pro', 176)
('overnight', 14)
('depleted', 3)
('phenotyping', 14)
('need', 4)
('concentration', 8)
('vitro', 18)
('relapse', 33)
('self', 4)
('il-15', 48)
('mechanism', 2)
('instance', 2)
('reactivity', 10)
('potential', 7)
('donor', 151)
('subject', 4)
('persistence', 10)
('supplementary material', 2)
('index', 2)
('white blood cell count', 4)
('wells', 2)
('virus', 8)
('eight', 12)
('significant', 13)
('class', 18)
('immunological', 4)
('acute lung injury', 4)
('kg', 30)
('informed consent', 2)
('infections', 6)
('disease', 17)
('cell survival', 6)
('human serum albumin', 2)
('findings', 2)
('mg\\/m2', 12)
('selection', 6)
('high dose', 6)
('mice', 6)
('principal', 4)
('completion', 4)
('cell', 488)
('mononuclear cells', 2)
('based', 10)
('nadir', 4)
('reactive', 30)
('only', 22)
('enriched', 8)
('investigational new drug application', 2)
('\\/ml', 16)
('dependent', 2)
('host response', 2)
('cd4', 16)
('low dose', 2)
('cd3', 40)
('bead', 6)
('beads', 2)
('median', 40)
('summary', 1)
('nk cell therapy', 17)
('activity', 24)
('release', 10)
('view', 12)
('short tandem repeat', 2)
('humans', 4)
('sex', 4)
('observed', 29)
('intensity', 2)
('result', 8)
('enhanced', 5)
('techniques', 2)
('inhibitory', 5)
('review', 4)
('approach', 2)
('variability', 2)
('ability', 8)
('relative', 6)
('missing', 6)
('lymphocyte', 10)
('wi', 131)
('killing', 13)
('extent', 6)
('nk cell', 265)
('disseminated herpes simplex', 4)
('cyclophosphamide', 2)
('3\\+', 16)
('blasts', 12)
('pcr', 4)
('transplantation', 2)
('context', 4)
('contribution', 2)
('t-cell depletion', 4)
('inflammatory', 8)
('overview', 4)
('ca', 127)
('cy', 83)
('cr', 91)
('red cell', 4)
('pr', 377)
('better', 6)
('addition', 4)
('40\\%', 10)
('product safety', 2)
('three', 6)
('pe', 169)
('immunosuppressive effect', 2)
('monoclonal', 2)
('resting', 12)
('cd56', 10)
('cytogenetic abnormalities', 4)
('efficacy', 4)
('influence', 2)
('2 weeks', 4)
('melphalan', 3)
('present', 40)
('exception', 2)
('hypotension', 6)
('il-15 secretion', 2)
('expanded', 2)
('mlr', 10)
('refractory', 2)
('near', 5)
('optimization', 1)
('stem cells', 2)
('31', 6)
('discontinuation', 2)
('characteristics', 2)
('iu', 10)
('interleukin-15', 1)
('preparative regimen', 4)
('vasopressor', 4)
('cohort', 10)
('immunosuppression', 2)
('combination', 2)
('sensitive', 4)
('administration', 14)
('cytometry', 2)
('th1', 2)
('phenotype', 2)
('prior therapy', 4)
('several', 4)
('composition', 4)
('european', 4)
('status', 2)
('responses', 11)
('kir', 88)
('pha', 33)
('effect', 24)
('kit', 2)
('levels', 36)
('i-', 26)
('recent', 4)
('lower', 4)
('undefined', 2)
('isotype', 4)
('disseminated', 4)
('myeloma', 6)
('analysis', 14)
('severe', 4)
('model', 2)
('protocol', 10)
('selection criteria', 2)
('medical sciences', 2)
('50\\%', 15)
('human', 11)
('alternative', 2)
('rosenberg', 2)
('transplant recipients', 2)
('irradiated', 4)
('tumour necrosis factor', 2)
('cell processing', 10)
('r\\.', 4)
('conjugated', 4)
('nkb1', 4)
('allele', 18)
('identical', 17)
('elevation', 8)
('aml', 2)
('hla-c', 36)
('survival', 14)
('early', 12)
('inhibition', 4)
('five', 14)
('burden', 4)
('recipient', 87)
('advanced', 1)
('stimulators', 2)
('partial response', 4)
('less than', 2)
('specific', 4)
('immunosuppressive', 5)
('side effects', 4)
('prophylaxis', 8)
('methods', 3)
('sequence', 2)
('cell line', 23)
('immunologic', 6)
('table', 20)
('duration', 4)
('consensus', 2)
('flow cytometry', 2)
('cooper', 4)
('broad', 2)
('tube', 2)
('endotoxin', 10)
('depletion', 6)
('cd14', 2)
('cd15', 10)
('population studies', 4)
('infectious disease', 2)
('minimal', 4)
('cd19', 2)
('bd', 4)
('patient', 203)
('bb', 2)
('k562', 27)
('activated nk cell', 4)
('host', 10)
('hsv', 4)
('ratios', 4)
('post', 47)
('manufacturing', 6)
('properties', 1)
('stage', 1)
('months', 8)
('range', 50)
('concentrations', 4)
('kir3dl1', 6)
('investigators', 6)
('antibody', 5)
('relapsed', 19)
('washington', 2)
('progressive disease', 4)
('elevated', 6)
('relapses', 4)
('additional', 2)
('growth factor', 2)
('support', 6)
('question', 4)
('long', 6)
('clinical', 14)
('low', 55)
('lot', 4)
('bortezomib', 2)
('nk cell numbers', 2)
('manufacture', 6)
('medium', 2)
('lymphopoiesis', 2)
('delayed', 11)
('volume', 4)
('failure', 1)
('alpha protein', 2)
('t cell', 20)
('polymerase chain reaction', 2)
('encoded', 2)
('line', 23)
('role', 13)
('neutropenia', 12)
('count', 30)
('grafts', 2)
('rejection', 12)
('cells', 279)
('maximum', 4)
('vivo', 20)
('infusions', 14)
('polymorphisms', 4)
('similar', 12)
('autologous', 18)
('cba', 2)
('measurement', 4)
('deer', 2)
('al', 543)
('transfused', 27)
('single', 12)
('laboratory', 2)
('ind', 35)
('serological', 2)
('dawson', 2)
('nk', 320)
('melanoma', 2)
('amounts', 4)
('nc', 175)
('\\/kg', 26)
('setting', 4)
('iu\\/ml', 8)
('il-6', 6)
('negative control', 4)
('variation', 5)
('important', 6)
('cytotoxicity', 10)
('fungal sinusitis', 4)
('age', 43)
('persistent', 2)
('transient', 14)
('validation', 4)
('proxy', 2)


total: 643('all', 159)
('influenza', 4)
('positive control', 4)
('delivery', 2)
('alleles', 2)
('epigenetic silencing', 2)
('four', 14)
('acute myeloid leukaemia', 1)
('mnc', 12)
('cytokines', 8)
('content', 2)
('amplification', 2)
('transferred', 2)
('mediated', 12)
('protocols', 2)
('immature', 2)
('heterogeneity', 2)
('endogenous', 5)
('brown', 2)
('assay', 18)
('hla-abc', 2)
('chlorophyll-alpha', 2)
('\\+2', 2)
('hypotension', 6)
('steady state', 2)
('condition', 18)
('timely', 4)
('pre', 137)
('engraftment', 4)
('level', 40)
('anti-kir', 2)
('large', 10)
('nk cell function', 2)
('allophycocyanin', 2)
('tnf-', 8)
('cell lines', 8)
('mn', 14)
('hypotensive episode', 8)
('occurrence', 2)
('ten', 72)
('triplicate', 2)
('antigen', 5)
('concentrations', 4)
('rate', 34)
('salvage therapy', 2)
('further', 20)
('targets', 4)
('mlr', 10)
('material', 2)
('primer', 2)
('cell', 488)
('clinical response', 2)
('mm\\/nk', 4)
('cd158b', 4)
('new', 4)
('increasing', 21)
('method', 5)
('completion', 4)
('kir-ligand', 15)
('transplant procedure', 2)
('fungal pneumonia', 4)
('\\>5', 4)
('genotyping', 10)
('residual', 4)
('normal tissue', 4)
('109', 30)
('others', 2)
('active', 36)
('donor selection', 4)
('anti-human', 3)
('institutional review board', 2)
('healthy', 4)
('study', 18)
('larger', 2)
('step', 4)
('killer immunoglobulin-like receptor', 2)
('products', 51)
('flu', 33)
('toxicity', 16)
('studies', 7)
('high resolution', 2)
('interferon', 2)
('family', 2)
('marked', 4)
('peridinin', 2)
('apc', 4)
('total', 4)
('transplant', 22)
('allogeneic', 2)
('usa', 18)
('complete remission', 1)
('positive', 12)
('two', 30)
('next', 8)
('t-cell', 9)
('therefore', 14)
('criteria', 10)
('stage', 1)
('more', 20)
('0\\%', 33)
('populations', 10)
('immunoglobulins', 2)
('mismatch', 18)
('infusion', 106)
('infection', 10)
('tandem', 6)
('8', 84)
('cases', 4)
('blocking', 11)
('97', 4)
('insights', 2)
('account', 2)
('peak level', 4)
('mm', 147)
('ml', 28)
('blade', 2)
('million units', 2)
('kir2dl1', 4)
('tnf', 10)
('era', 81)
('mr', 4)
('early relapse', 4)
('salvage', 16)
('liposomal', 4)
('control', 20)
('figure', 6)
('nkg2a\\+\\/kir', 2)
('process', 16)
('alloreactive', 4)
('days', 8)
('high', 17)
('kir2dl2', 12)
('fludarabine', 5)
('numbers', 6)
('serial', 4)
('serum', 16)
('absolute', 16)
('recovery', 4)
('s3', 6)
('s2', 6)
('s1', 8)
('six', 4)
('1', 365)
('chiron', 2)
('cell-mediated cytotoxicity', 4)
('product', 89)
('cytokine', 16)
('rigors', 4)
('fitc', 4)
('clone', 2)
('cd33', 2)
('cd34', 8)
('51cr', 2)
('american red cross', 2)
('modest', 4)
('mab', 2)
('host response', 2)
('data', 23)
('response', 27)
('a', 4120)
('natural', 1)
('effective', 8)
('t cells', 20)
('stable disease', 6)
('hla class i', 18)
('cs1', 2)
('discussion', 2)
('sd', 8)
('transplants', 2)
('k562 cells', 8)
('in-house', 6)
('hla-drb1', 2)
('years', 4)
('cd3-depleted', 2)
('experiments', 2)
('th1', 2)
('infusion reaction', 2)
('kbq', 2)
('nkg2a', 4)
('blocked', 4)
('superior', 4)
('group', 32)
('ligand', 35)
('\\>97', 2)
('allo', 60)
('late', 35)
('interleukin-2', 2)
('production', 2)
('fig', 48)
('phenotype', 2)
('donors', 22)
('non', 8)
('good', 4)
('remission', 6)
('auto', 54)
('killer', 3)
('primary', 24)
('therapy', 34)
('mismatched', 16)
('day', 40)
('instructions', 2)
('very large tumour', 2)
('university', 2)
('drop', 2)
('conditioning regimen', 5)
('composition', 4)
('normal cell', 2)
('progressive disease', 4)
('ifn', 10)
('investigators', 6)
('week', 6)
('post-infusion', 4)
('molecular typing', 2)
('house', 6)
('related', 9)
('autologous stem cell transplantation', 1)
('doses', 10)
('lysis', 24)
('event', 11)
('hla', 82)
('herpes simplex virus', 4)
('malignancies', 2)
('increase', 12)
('mate', 14)
('arkansas', 2)
('cd4\\+', 16)
('derived', 2)
('standard', 16)
('ex-vivo', 2)
('cd3\\+\\/4\\+', 4)
('mononuclear', 2)
('il\\-15\\.', 6)
('dexamethasone', 2)
('peripheral blood', 4)
('interaction', 9)
('kir ligand', 8)
('w6\\/32', 6)
('times', 4)
('r-', 35)
('chills', 4)
('first', 20)
('degree', 2)
('steroids', 4)
('number', 31)
('one', 44)
('body weight', 8)
('array', 4)
('\xc3\x97', 58)
('size', 2)
('carson', 2)
('genotype', 2)
('mixed lymphocyte culture', 2)
('nk cells', 118)
('hlac\\*', 2)
('system', 4)
('approximately', 6)
('stimulation', 2)
('2', 452)
('typing', 34)
('chemotherapy', 2)
('percentage', 20)
('cell interaction', 5)
('final', 2)
('schema', 2)
('testing', 10)
('aphaeresis', 12)
('pcr', 4)
('hla-bw4', 8)
('stem cell', 5)
('population', 22)
('wide', 4)
('target', 9)
('double', 4)
('malignancies\\.', 2)
('mlrs', 4)
('pha-blasts', 10)
('pneumonia', 8)
('patients', 161)
('future', 3)
('outcome', 16)
('treated', 22)
('viable cells', 2)
('chlorophyll', 2)
('san', 6)
('lines', 8)
('pro', 176)
('overnight', 14)
('depleted', 3)
('phenotyping', 14)
('need', 4)
('concentration', 8)
('vitro', 18)
('relapse', 33)
('self', 4)
('il-15', 48)
('il-10', 6)
('elisa', 2)
('instance', 2)
('reactivity', 10)
('potential', 7)
('donor', 151)
('subject', 4)
('persistence', 10)
('supplementary material', 2)
('normal', 14)
('white blood cell count', 4)
('wells', 2)
('virus', 8)
('abc', 2)
('eight', 12)
('significant', 13)
('class', 18)
('immunological', 4)
('acute lung injury', 4)
('kg', 30)
('informed consent', 2)
('responder', 6)
('infections', 6)
('disease', 17)
('cell survival', 6)
('0702', 2)
('human serum albumin', 2)
('findings', 2)
('mg\\/m2', 12)
('selection', 6)
('high dose', 6)
('miller', 10)
('percp', 2)
('mice', 6)
('principal', 4)
('kir-ligands', 1)
('cd158a', 4)
('mononuclear cells', 2)
('based', 10)
('nadir', 4)
('window', 2)
('receptors', 10)
('reactive', 30)
('only', 22)
('enriched', 8)
('factor', 4)
('investigational new drug application', 2)
('\\/ml', 16)
('dependent', 2)
('dc', 2)
('multiple myeloma', 1)
('cd4', 16)
('low dose', 2)
('cd3', 40)
('bead', 6)
('rejection', 12)
('beads', 2)
('median', 40)
('summary', 1)
('nk cell therapy', 17)
('activity', 24)
('release', 10)
('pro-inflammatory', 8)
('view', 12)
('hla\\-c\\*0304', 2)
('short tandem repeat', 2)
('humans', 4)
('sex', 4)
('observed', 29)
('intensity', 2)
('result', 8)
('enhanced', 5)
('techniques', 2)
('preparation', 4)
('inhibitory', 5)
('review', 4)
('approach', 2)
('variability', 2)
('ability', 8)
('relative', 6)
('missing', 6)
('lymphocyte', 10)
('cd3\\+', 16)
('killing', 13)
('wi', 131)
('extent', 6)
('nk cell', 265)
('disseminated herpes simplex', 4)
('cyclophosphamide', 2)
('3\\+', 16)
('blasts', 12)
('sensitive', 4)
('transplantation', 2)
('context', 4)
('irradiated', 4)
('contribution', 2)
('t-cell depletion', 4)
('assays\\.', 2)
('inflammatory', 8)
('overview', 4)
('ca', 127)
('cy', 83)
('ab', 129)
('0\\.038', 8)
('table', 20)
('red cell', 4)
('pr', 377)
('better', 6)
('tumour', 10)
('addition', 4)
('40\\%', 10)
('product safety', 2)
('three', 6)
('kir receptor', 8)
('pe', 169)
('4-h', 2)
('immunosuppressive effect', 2)
('monoclonal', 2)
('resting', 12)
('cd56', 10)
('cytogenetic abnormalities', 4)
('efficacy', 4)
('influence', 2)
('2 weeks', 4)
('melphalan', 3)
('present', 40)
('exception', 2)
('phycoerythrin', 2)
('il-15 secretion', 2)
('expanded', 2)
('cytokines\\.', 4)
('aim', 2)
('refractory', 2)
('near', 5)
('optimization', 1)
('stem cells', 2)
('allo-reactive', 26)
('leucocyte', 1)
('31', 6)
('discontinuation', 2)
('characteristics', 2)
('hlabw4', 4)
('iu', 10)
('interleukin-15', 1)
('ii', 6)
('preparative regimen', 4)
('conditioning', 16)
('vasopressor', 4)
('interactions\\.', 4)
('protein', 2)
('cohort', 10)
('immunosuppression', 2)
('combination', 2)
('administration', 14)
('cytometry', 2)
('same', 4)
('haplo-identical', 17)
('pneumonia\\.', 4)
('prior therapy', 4)
('several', 4)
('hla-a', 4)
('european', 4)
('status', 2)
('responses', 11)
('practice', 4)
('kir', 88)
('pha', 33)
('effect', 24)
('kit', 2)
('levels', 36)
('i-', 26)
('recent', 4)
('lower', 4)
('undefined', 2)
('i', 4346)
('disseminated', 4)
('myeloma', 6)
('analysis', 14)
('severe', 4)
('hla-ligand', 2)
('cd56\\+', 4)
('model', 2)
('effects', 10)
('protocol', 10)
('selection criteria', 2)
('medical sciences', 2)
('-ligand', 18)
('50\\%', 15)
('mechanism', 2)
('human', 11)
('alternative', 2)
('cd34\\+', 8)
('rosenberg', 2)
('transplant recipients', 2)
('\\?', 42)
('tumour necrosis factor', 2)
('cell processing', 10)
('r\\.', 4)
('conjugated', 4)
('4', 148)
('nkb1', 4)
('lymphocytes', 2)
('allele', 18)
('\\,', 532)
('donor-derived', 2)
('\\(', 334)
('\\)', 334)
('identical', 17)
('elevation', 8)
('aml', 2)
('hla-c', 36)
('survival', 14)
('early', 12)
('inhibition', 4)
('five', 14)
('burden', 4)
('recipient', 87)
('advanced', 1)
('kir-receptor', 4)
('stimulators', 2)
('partial response', 4)
('less than', 2)
('specific', 4)
('immunosuppressive', 5)
('t', 4763)
('side effects', 4)
('prophylaxis', 8)
('methods', 3)
('sequence', 2)
('cell line', 23)
('supplementary', 2)
('immunologic', 6)
('growth', 2)
('cr', 91)
('duration', 4)
('consensus', 2)
('flow cytometry', 2)
('cooper', 4)
('broad', 2)
('tube', 2)
('endotoxin', 10)
('depletion', 6)
('cd14', 2)
('cd15', 10)
('population studies', 4)
('infectious disease', 2)
('minimal', 4)
('cd19', 2)
('bd', 4)
('\\/kir', 4)
('patient', 203)
('bb', 2)
('k562', 27)
('activated nk cell', 4)
('stem', 9)
('host', 10)
('hsv', 4)
('il-2', 56)
('ratios', 4)
('infiltrating', 2)
('post', 47)
('manufacturing', 6)
('neutrophil', 4)
('properties', 1)
('manufacturer', 2)
('isotype', 4)
('months', 8)
('range', 50)
('mixed', 2)
('kir3dl1', 6)
('mean', 2)
('antibody', 5)
('hla\\-bw4\\.', 4)
('relapsed', 19)
('washington', 2)
('anti-cd3', 2)
('receptor', 18)
('elevated', 6)
('cells\\.', 41)
('relapses', 4)
('\\/l', 34)
('u266', 25)
('additional', 2)
('growth factor', 2)
('support', 6)
('question', 4)
('long', 6)
('clinical', 14)
('low', 55)
('lot', 4)
('bortezomib', 2)
('cultures', 2)
('nk cell numbers', 2)
('manufacture', 6)
('medium', 2)
('lymphopoiesis', 2)
('delayed', 11)
('volume', 4)
('failure', 1)
('alpha protein', 2)
('t cell', 20)
('polymerase chain reaction', 2)
('encoded', 2)
('line', 23)
('role', 13)
('neutropenia', 12)
('count', 30)
('grafts', 2)
('immunoglobulin-like', 2)
('cells', 279)
('maximum', 4)
('vivo', 20)
('infusions', 14)
('polymorphisms', 4)
('similar', 12)
('age', 43)
('autologous', 18)
('ifn-', 8)
('cba', 2)
('measurement', 4)
('deer', 2)
('al', 543)
('transfused', 27)
('single', 12)
('laboratory', 2)
('ind', 35)
('serological', 2)
('dawson', 2)
('nk', 320)
('melanoma', 2)
('amounts', 4)
('index', 2)
('nc', 175)
('\\/kg', 26)
('setting', 4)
('iu\\/ml', 8)
('il-4', 6)
('il-6', 6)
('negative control', 4)
('variation', 5)
('important', 6)
('cytotoxicity', 10)
('fungal sinusitis', 4)
('necrosis', 2)
('persistent', 2)
('transient', 14)
('validation', 4)
('proxy', 2)
